NCT06645093View on ClinicalTrials.gov

Feasibility of Intermittent Fasting During Chemotherapy

NAEnrolling by invitationINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
LymphomaCancerFasting
Interventions
OTHER

Fasting

Fasting implies 0 kilojoule. Water ad libitum is permitted.

Trial Locations (1)

0372

Department of Nutrition, University of Oslo, Oslo

All Listed Sponsors
collaborator

Oslo University Hospital

OTHER

lead

University of Oslo

OTHER